Archean Chemical Industries: Business Overview & Financial Analysis
Archean Chemical Industries is a leading Indian specialty marine chemical manufacturer headquartered in Chennai, Tamil Nadu. Promoted by the Pendurthi and Ranjit Pratap families, the enterprise produces and exports industrial salt, elemental bromine, and sulphate of potash (SOP) derived from marine brine resources. Operating integrated solar saltworks and processing complexes at Hajipir in the Rann of Kutch, Gujarat, the company serves global industrial customers across Asia, Europe, and the Middle East, supplying feedstock to flame retardants, pharmaceuticals, agrochemicals, and water treatment sectors.
Product Segment Breakdown of Archean Chemical Industries (Q1 FY2027)
Archean Chemical Industries structures its operational turnover across marine chemical product lines and value-added derivative subsidiaries.
- Industrial Salt Division Share – 51.5% of Consolidated Revenue (Rs 1,713.00 million / 0.98 million MT)
- Elemental Bromine Division Share – Core Specialty Chemical Revenue Driver
- Acume Chemicals (Bromine Derivatives) Share – Rs 296.00 million (+28.0% YoY)
- Sulphate of Potash (SOP) Division Share – Rs 113.00 million (vs Rs 35.00 million in FY2026)
- Total Consolidated Revenue from Operations (Q1 FY2027) – Rs 3,328.00 million / Rs 332.80 crore (+11.0% YoY)
Industrial salt exports account for over half of total turnover, supplying chlorine and caustic soda manufacturers across East Asia. Bromine and downstream derivatives from subsidiary Acume Chemicals provide high-margin growth across agrochemical and flame retardant applications.
Geographic Revenue Mix & Export Distribution of Archean Chemical Industries (FY2026)
The company exports specialty marine chemicals across international markets and supplies domestic chemical processors.
- Export Market Revenue Contribution – ~70.0% of Total Operating Income
- Domestic Indian Market Share – ~30.0% of Total Operating Income
- Primary Overseas Export Destinations – Japan, China, South Korea, Qatar, Belgium, and Europe
- Industrial Salt Export Market Position – Leading merchant exporter of industrial salt from India
International export shipments contribute nearly seven-tenths of annual turnover, supported by direct port access at Jakhau and Mundra in Gujarat. Industrial salt dispatches to East Asian chlor-alkali producers anchor baseline export volumes.
Key Operational Metrics & Capacity Scale of Archean Chemical Industries (Q1 FY2027)
Archean Chemical Industries tracks quarterly chemical dispatch volumes, solar pond evaporation yields, and derivative capacity utilization rates.
- Quarterly Industrial Salt Dispatch Volume – 0.98 million Metric Tonnes (MT)
- Targeted Annual Bromine Volume Run-Rate – 20,000 to 25,000 MT by end of FY2027 (40,000 MT by FY2029)
- Active Solar Evaporative Brine Ponds Area – ~100,000 acres in the Rann of Kutch
- Acume Chemicals Subsidiary EBITDA Status – Turnaround to Positive EBITDA of Rs 19.00 million (vs Rs -27.00 million in Q1 FY2026)
- Total Marine Reserve Lease Term – Multi-decade salt works lease in Hajipir, Gujarat
Operating salt works across ~100,000 acres of solar evaporation ponds ensures continuous feedstock recovery for bromine and salt extraction. Turnaround of subsidiary Acume Chemicals to positive EBITDA highlights commercial scale-up of downstream bromine derivatives.
Latest Quarterly Financial Performance of Archean Chemical Industries (Q1 FY2027)
Archean Chemical Industries recorded top-line revenue expansion alongside margin adjustments during the first quarter of FY2027.
- Consolidated Revenue from Operations – Rs 332.80 crore / Rs 3,328.00 million (+11.0% YoY vs Rs 299.80 crore)
- Consolidated Operating EBITDA – Rs 72.90 crore / Rs 729.00 million (21.9% margin)
- Standalone Operating EBITDA – Rs 83.90 crore / Rs 839.00 million (25.3% margin)
- Consolidated Profit After Tax (PAT) – Rs 30.40 crore / Rs 304.00 million (-24.2% YoY vs Rs 40.10 crore)
- Consolidated Diluted Earnings Per Share (EPS) – Rs 2.48 per share (vs Rs 3.25 in Q1 FY2026)
- Primary Freight Impact – Other operating expenses rose to Rs 210.00 crore due to road repair detours in Gujarat
First-quarter consolidated operating revenue expanded 11.0% year-on-year to Rs 332.80 crore, supported by bromine pricing and SOP production gains. Consolidated Net Profit After Tax reached Rs 30.40 crore, as mandated road repair detours in Gujarat temporarily inflated per-liter logistics costs.
Consolidated Annual Financial Performance of Archean Chemical Industries (FY2026)
The enterprise delivered full-year turnover realisations and cash generation during full financial year FY2026.
- Full Year Consolidated Revenue from Operations – Rs 1,335.50 crore
- Full Year Consolidated Operating EBITDA – Rs 412.30 crore
- Full Year Operating EBITDA Margin – 30.87%
- Full Year Consolidated Net Profit After Tax (PAT) – Rs 224.80 crore
- Return on Capital Employed (ROCE) Realisation – 18.50%
- Return on Equity (ROE) Realisation – 14.80%
Full-year operating turnover crossed Rs 1,330.00 crore in FY2026, while Net Profit After Tax reached Rs 224.80 crore. Delivering an operating EBITDA margin of 30.87% reflects low-cost solar brine extraction capabilities.
Balance Sheet Structure & Financial Health Ratios of Archean Chemical Industries (Q1 FY2027)
Archean Chemical Industries maintains a conservative net debt-free financial structure supported by cash reserves and equity retention.
- Financial Debt Status – Net Debt-Free / Net Cash Surplus
- Consolidated Finance Costs (Q1 FY2027) – Rs 5.50 crore / Rs 55.00 million
- Total Consolidated Net Worth Base – ~Rs 1,750.00 crore
- Working Capital Conversion Cycle – 65 days
- Credit Rating Status – Reaffirmed high investment grade credit rating profile
Operating a net debt-free balance sheet provides financial resilience against global commodity freight fluctuations. Consolidated finance costs remained controlled at Rs 5.50 crore during the quarter.
Capex Outlay & Business Expansion Pipeline of Archean Chemical Industries (FY2027–FY2028)
The enterprise executes strategic capital outlays to expand bromine derivatives, commercialize SOP Phase 2, and enter semiconductor material manufacturing.
- Semiconductor Silicon Project (SiCSem Subsidiary) Capex – USD 249.00 million (~Rs 2,075.00 crore) total project outlay
- FY2027 Semiconductor Capex Deployment – 60% to 65% of total USD 249 million outlay to be spent in FY2027
- Pre-Incurred Semiconductor Capex – 15% to 20% already incurred prior to FY2027
- Remaining Semiconductor Capex Target – 40% to 45% to be deployed in FY2028
- Sulphate of Potash (SOP) Phase 2 Target – Completion by Q3 FY2027 to enable full commercial scaling
Deploying 60%–65% of the USD 249 million semiconductor capex in FY2027 advances clean-room and equipment setup for subsidiary SiCSem. Completing SOP Phase 2 in Q3 FY2027 unlocks full commercial scale-up of potassium fertilizer extraction.
Strategic Outlook & Management Commentary of Archean Chemical Industries (Q1 FY2027 Concall)
Management guidance outlines strategic priorities centered on volume growth, logistics recovery, and semiconductor execution.
- Management projects double-digit volume growth recovery starting Q3 FY2027 across salt and bromine segments.
- Annual bromine sales volume run-rate is targeted to reach 20,000 to 25,000 tonnes by the end of FY2027 and 25,000 tonnes in FY28.
- Long-term bromine capacity run-rate is targeted at 40,000 tonnes by FY2028–FY2029 to feed flame retardant plants.
- Operating EBITDA margins are expected to recover in H2 FY2027 as Gujarat road repair detours clear and freight normalises.
- Semiconductor project construction (SiCSem) will ramp up with full commercial operations targeted 24–27 months post-commencement.
- Oilfield drilling chemicals business is conducting active customer trials for mud chemicals, bentonite, and starch products.
- Capital allocation strategy prioritizes self-funded capex outlays while maintaining disciplined balance sheet leverage.
Management remains confident of driving top-line acceleration through derivative volume growth and logistics normalisation. Operational priorities focus on executing the USD 249 million SiCSem project, completing SOP Phase 2, and expanding bromine export volumes.
Want to filter out stocks based on your own investment criteria? You can use the Stock Screener on Finology Ticker to evaluate stocks based on customised valuation and profitability parameters.
Sources & References
- Archean Chemical Industries Q1 FY2027 Investor Presentation & Financial Outcome Slides (August 3, 2026)
- Archean Chemical Industries Q1 FY2027 Earnings Conference Call Transcript & Highlights (August 25, 2026)
- Stock Exchange Disclosures & Corporate Filings for Archean Chemical Industries
- BSE Limited & National Stock Exchange of India (NSE) Filings for Archean Chemical Industries
- Ticker Finology Archean Chemical Industries Page
Disclaimer
The information presented above on Archean Chemical Industries has been compiled from the company's Annual Reports, Investor Presentations, Earnings Call (Concall) Transcripts, official regulatory filings and the financial data available on Finology Ticker. Certain figures, classifications or comparisons may vary due to differences in accounting policies, reporting methodologies or subsequent restatements by the company. This content is intended solely for informational purposes and should not be considered as investment advice. Investors are advised to refer to the latest company filings and the updated financial data, ratios and disclosures available on this Finology Ticker Archean Chemical Industries page before making any investment decision. Investment in securities market are subject to market risks. Read all the related documents carefully before investing.